1165563

Celgene Corporation — FEI 3004991673

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 14, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Summit, NJ (United States)

Additional Details

Sponsor, Contract Research Organization